Differential Modulation of Glutamatergic Transmission by 3,5-Dibromo-l-phenylalanine

@article{Yarotskyy2005DifferentialMO,
  title={Differential Modulation of Glutamatergic Transmission by 3,5-Dibromo-l-phenylalanine},
  author={V. Yarotskyy and A. Glushakov and C. Sumners and N. Gravenstein and D. Dennis and C. Seubert and A. Martynyuk},
  journal={Molecular Pharmacology},
  year={2005},
  volume={67},
  pages={1648 - 1654}
}
An increasing body of evidence supports the hypothesis that diminished function of N-methyl-d-aspartate (NMDA) receptors and the associated increase in glutamate release and overstimulation of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/kainate receptors are critical elements of the pathophysiology of schizophrenia. Here, we describe a halogenated derivative of the aromatic amino acid l-phenylalanine that 1) activates NMDA receptors, 2) depresses presynaptic glutamate release… Expand
4 Citations
Impaired glutamatergic synaptic transmission in the PKU brain.
  • 46
Novel N-methyl-d-aspartate receptor antagonists: a review of compounds patented since 2006
  • 32
Efficacy of 3,5‐dibromo‐L‐phenylalanine in rat models of stroke, seizures and sensorimotor gating deficit
  • 8

References

SHOWING 1-10 OF 31 REFERENCES
Neuroprotective Action of Halogenated Derivatives of L-Phenylalanine
  • 22
  • PDF
Activation of Glutamate Neurotransmission in the Prefrontal Cortex Sustains the Motoric and Dopaminergic Effects of Phencyclidine
  • 130
  • PDF
L‐phenylalanine selectively depresses currents at glutamatergic excitatory synapses
  • 39
Regulation of Neurotransmitter Release by Metabotropic Glutamate Receptors
  • 846
The Neuropsychopharmacology of Phencyclidine: From NMDA Receptor Hypofunction to the Dopamine Hypothesis of Schizophrenia
  • 1,209
  • PDF
...
1
2
3
4
...